Correlation Between Entero Therapeutics, and Apollomics
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and Apollomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and Apollomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and Apollomics Class A, you can compare the effects of market volatilities on Entero Therapeutics, and Apollomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of Apollomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and Apollomics.
Diversification Opportunities for Entero Therapeutics, and Apollomics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Entero and Apollomics is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and Apollomics Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apollomics Class A and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with Apollomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apollomics Class A has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and Apollomics go up and down completely randomly.
Pair Corralation between Entero Therapeutics, and Apollomics
Given the investment horizon of 90 days Entero Therapeutics, is expected to generate 2.96 times less return on investment than Apollomics. But when comparing it to its historical volatility, Entero Therapeutics, is 1.66 times less risky than Apollomics. It trades about 0.08 of its potential returns per unit of risk. Apollomics Class A is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 633.00 in Apollomics Class A on August 25, 2025 and sell it today you would earn a total of 813.00 from holding Apollomics Class A or generate 128.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Entero Therapeutics, vs. Apollomics Class A
Performance |
| Timeline |
| Entero Therapeutics, |
| Apollomics Class A |
Entero Therapeutics, and Apollomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entero Therapeutics, and Apollomics
The main advantage of trading using opposite Entero Therapeutics, and Apollomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, Apollomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollomics will offset losses from the drop in Apollomics' long position.| Entero Therapeutics, vs. Curis Inc | Entero Therapeutics, vs. Processa Pharmaceuticals | Entero Therapeutics, vs. Briacell Therapeutics Corp | Entero Therapeutics, vs. Palisade Bio |
| Apollomics vs. LMF Acquisition Opportunities | Apollomics vs. Moleculin Biotech | Apollomics vs. Athira Pharma | Apollomics vs. Lunai Bioworks |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |